RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results
Go back to RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.93 | 52 Week High | $16.54 | |||
| Open | $0.93 | 52 Week Low | $8.10 | |||
| Day High | $0.93 | P/E | N/A | |||
| Day Low | $0.93 | EPS | $0.00 | |||
| Volume | 2,034 | |||||
